Document is current
Any future updates will be listed below
-
Authors
van Deuren, Rosanne C.
Arts, Peer
Cavalli, Giulio
Jaeger, Martin
Steehouwer, Marloes
van de Vorst, Maartje
Gilissen, Christian
Joosten, Leo A. B.
Dinarello, Charles A.
Mhlanga, Musa M.
Kumar, Vinod
Netea, Mihai G.
van de Veerdonk, Frank L.
Hoischen, Alexander http://orcid.org/0000-0002-8072-4476
-
Funding
Funding for this research was provided by:
Competitiveness Operational Programme grant of the Romanian Ministry of European Funds ((HINT, P_37_762, MySMIS 103587))
South African Medical Research Council, Department of Science & Technology of South Africa
Chan Zuckerberg Initiative
Bill and Melinda Gates Foundation
Hypatia tenure track fellowship
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
European Research Council ((310372))
Interleukin Foundation for Medical Research
Horizon 2020 (779257)
- License Information
-
More Information
Article History
Received: 4 December 2020
Accepted: 11 May 2021
First Online: 25 May 2021
Declarations
:
: Samples were obtained from a previously published study [CitationRef removed], for which ethics approval was obtained: the HFGP study was approved by the Ethical Committee of Radboud University Nijmegen, the Netherlands (no. 42561.091.12). Patients provided written informed consent and the research conformed to the principles of the Helsinki Declaration. Samples of venous blood were drawn after informed consent was obtained.
: Not applicable.
: LABJ reports to be Scientific Advisory Board member of Olatec Therapeutics LLC. CAD serves as chair of SAB of Olatec Therapeutics LLC. The remaining authors declare that they have no competing interests.
